Financial Reports
Latest Updates
StemRIM Inc. (4599) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-08-03 | — | StemRIM Announces Patent Registration for SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in South Korea | |
| 2026-07-22 | — | StemRIM Announces Patent Registration (Mexico) for Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders | |
| 2026-07-13 | — | StemRIM Announces Patent Registration (Canada) for Redasemtide, as an Additional Therapeutic Indication for Cardiomyopathy, Old Myocardial Infarction |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.